VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $924 | -92.7% | 57,000 | -92.5% | 0.00% | -94.1% |
| Q1 2023 | $12,674 | +41.8% | 761,200 | -19.9% | 0.02% | +41.7% |
| Q4 2022 | $8,936 | -99.7% | 950,600 | -9.2% | 0.01% | +200.0% |
| Q3 2022 | $2,846,000 | +13.7% | 1,046,400 | +20.8% | 0.00% | +33.3% |
| Q2 2022 | $2,503,000 | -13.7% | 866,200 | -10.5% | 0.00% | 0.0% |
| Q1 2022 | $2,902,000 | +159.8% | 967,349 | +298.3% | 0.00% | +200.0% |
| Q4 2021 | $1,117,000 | +10.8% | 242,873 | +35.7% | 0.00% | 0.0% |
| Q4 2020 | $1,008,000 | +366.7% | 179,000 | +382.5% | 0.00% | – |
| Q3 2020 | $216,000 | -94.1% | 37,100 | -95.5% | 0.00% | -100.0% |
| Q2 2018 | $3,638,000 | 0.0% | 832,500 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $3,638,000 | -0.8% | 832,500 | -7.8% | 0.00% | 0.0% |
| Q4 2017 | $3,667,000 | +376.9% | 903,300 | +124.4% | 0.00% | +300.0% |
| Q3 2017 | $769,000 | +138.1% | 402,600 | +34.6% | 0.00% | – |
| Q2 2017 | $323,000 | -16.8% | 299,000 | +12.5% | 0.00% | -100.0% |
| Q1 2017 | $388,000 | +100.0% | 265,800 | +62.9% | 0.00% | – |
| Q4 2016 | $194,000 | +546.7% | 163,200 | +666.2% | 0.00% | – |
| Q3 2016 | $30,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |